Hydrochloric Acid

Hydrochloric Acid

SCHEMBL580839

Cl.Nc1nc(N)nc(N)n1

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA known ✓ P10253 1/20 0.32
HSP90AB1 known ✓ P08238 1/20 0.32
HSP90AA1 known ✓ P07900 1/20 0.31
HTR2B known ✓ P41595 1/20 0.31
PDE4D known ✓ Q08499 1/20 0.31
CASP1 P29466 1/20 0.47
LMNA P02545 2/20 0.42
ADORA2A P29274 2/20 0.40
ADORA1 P30542 2/20 0.40
POLB P06746 1/20 0.40
ADORA3 P0DMS8 1/20 0.40
ADORA2B P29275 1/20 0.40
CYP1A2 P05177 1/20 0.38
NPC1 O15118 4/20 0.36
RAB9A P51151 4/20 0.36
KDM4E B2RXH2 3/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
ALOX15 P16050 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3341380 1.00 CASP1 (0.47) CASP1LMNAADORA2AADORA1POLB
Hydrochloric Acid SCHEMBL28299308 1.00 CASP1 (0.47) CASP1LMNAADORA2AADORA1POLB
Hydrochloric Acid SCHEMBL30388037 1.00 CASP1 (0.47) CASP1LMNAADORA2AADORA1POLB
Hydrochloric Acid SCHEMBL586764 1.00 CASP1 (0.47) CASP1LMNAADORA2AADORA1POLB
Hydrochloric Acid SCHEMBL28275754 0.95 CASP1 (0.44) CASP1LMNAADORA2AADORA1POLB
SCHEMBL8465809 0.94 CASP1 (0.50) CASP1LMNAADORA2AADORA1POLB
SCHEMBL9579151 0.94 CASP1 (0.50) CASP1LMNAADORA2AADORA1POLB
SCHEMBL175612 0.94 CASP1 (0.50) CASP1LMNAADORA2AADORA1POLB
SCHEMBL25853 0.94
SCHEMBL29900242 0.94

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 357 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260108946-A1 LOW-TEMPERATURE CASE HARDENING OF ADDITIVE MANUFACTURED ARTICLES AND MATERIALS AND TARGETED APPLICATION OF SURFACE MODIFICATION SWAGELOK CO (US) 2026-04-23 US claimed
US-20260002244-A1 ACTIVATION OF SELF-PASSIVATING METALS USING REAGENT COATINGS FOR LOW TEMPERATURE NITROCARBURIZATION IN THE PRESENCE OF OXYGEN-CONTAINING GAS SWAGELOK CO (US) 2026-01-01 US claimed
US-12435406-B2 Activation of self-passivating metals using reagent coatings for low temperature nitrocarburization in the presence of oxygen-containing gas SWAGELOK COMPANY (US) 2025-10-07 US claimed
CN-114929924-B Chemical activation of self-passivating metals 斯瓦戈洛克公司 2025-02-14 CN claimed
CN-119300479-A Efficient battery assembly and preparation method thereof 江苏东鋆光伏科技有限公司 2025-01-10 CN claimed
CN-115178294-B PDI functionalized 3D g-C3N4Preparation method and application of photocatalyst 江苏大学 2024-12-06 CN claimed
CN-115404081-B Passivating agent for repairing heavy metal arsenic, lead and cadmium combined pollution and application thereof 广西壮族自治区环境保护科学研究院 2024-10-11 CN claimed
CN-118324123-A Nitrogen-doped carbon micro-tube and preparation method thereof 大连理工大学 2024-07-12 CN claimed
CN-118147691-A Preparation method of hydrogen production catalyst in carbon-hydrogen co-production 黑龙江博能绿色能源科技股份有限公司 2024-06-07 CN claimed
CN-114471655-B Preparation method of composite photocatalyst capable of efficiently generating hydrogen peroxide without adding sacrificial agent under visible light 山西省生态环境保护服务中心(山西省环境规划院) 2024-05-31 CN claimed
WO-2016057253-A1 DISPERSANT FOR USE IN SYNTHESIS OF POLYARYLETHERKETONES TICONA LLC (US) 2016-04-14 WO claimed
EP-1576073-B1 FIRE RESISTANT MATERIAL COMMW SCIENT IND RES ORG (AU) 2012-02-15 EP claimed
US-20110281981-A1 FIRE RESISTANT MATERIAL THE BOEING COMPANY 2011-11-17 US claimed
WO-2004039916-A9 FIRE RESISTANT MATERIAL COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2009-10-29 WO claimed
US-20070194289-A1 Fire resistant material Commonwealth Scientific & Industrial Research Org. a Australian Corporation 2007-08-23 US claimed
US-20050019579-A1 Carbon material and process of manufacturing CHAPMAN LLOYD R (US) 2005-01-27 US claimed
CN-1177973-C Nano material modified high strength paper and its preparation method 中国科学院化学研究所 2004-12-01 CN claimed
US-20040142173-A1 Carbon material and process of manufacturing EQUITY ENTERPRISES 2004-07-22 US claimed
CN-1414176-A Nano material modified high strength paper and its preparation method CHEMICAL INST CHINESE ACADEMY (CN) 2003-04-30 CN claimed
US-4028333-A POLYOLEFINS VELSICOL CHEMICAL CORPORATION (US) 1977-06-07 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260002244-A1 ACTIVATION OF SELF-PASSIVATING METALS USING REAGENT COATINGS FOR LOW TEMPERATURE NITROCARBURIZATION IN THE PRESENCE OF OXYGEN-CONTAINING GAS NOS2, GSDMD, NOS1 GAA 2271/4885HSP90AB1 698/4885HSP90AA1 954/4885
US-20260108946-A1 LOW-TEMPERATURE CASE HARDENING OF ADDITIVE MANUFACTURED ARTICLES AND MATERIALS AND TARGETED APPLICATION OF SURFACE MODIFICATION NOS2, NIT2, NSUN2 GAA 667/4885HSP90AB1 151/4885HSP90AA1 186/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.